Abstract
The tumor suppressor protein p53 plays a central role in the multiple response pathways activated by DNA damage. In particular, p53 is involved in both the pro-survival response of cell cycle arrest and DNA repair, and the pro-death response of apoptosis. How does the p53 network coordinate the different pathways that lead to the opposite cell fates and what is its strategy in making the life-death decisions? To address these questions, we develop an integrated mathematical model that embraces three key modules of the p53 network: p53 core regulation, p53-induced cell cycle arrest and p53-dependent apoptosis initiation. Our analyses reveal that different aspects of the nuclear p53 dynamic profile are being used to differentially regulate the pro-survival and the pro-death modules. While the activation of the pro-survival module is dependent on the current or recent status of the DNA damage, the activation of the pro-death module relies on the accumulation or integration of the damage level over time. Thus, the cell will take the death fate if it cannot recover from the damage within a time period that is inversely proportional to the damage level. This “adaptive timer” strategy is likely to be adopted in other stress response systems.
1. Introduction
The tumor suppressor protein p53 can promote both pro-survival and pro-death responses, simultaneously playing key regulatory roles in the cell’s stress response pathways leading to the two opposite cell fates (Braithwaite & Prives, 2006). In response to DNA damage, elevated p53 induces the transcription of a series of “pro-survival” proteins, such as p21, 14-3-3 and p53R2, to arrest the cell cycle and to repair the damaged DNA (Gatz & Wiesmuller, 2006; Kuerbitz et al., 1992). On the other hand, p53 also has transcriptional and non-transcriptional functions to trigger apoptosis, the cell’s suicidal program to kill itself (Chipuk & Green, 2006; Polyak et al., 1997). For the same cell type, the intensity of cellular stress is an important determinant of the cell fate, especially for radiation-caused DNA damage (Fei & El-Deiry, 2003). Cells with repairable damage usually prefers survival, while severe damage typically leads to cell death (Fei & El-Deiry, 2003; Speidel et al., 2006). Although various parts of the p53-mediated stress response pathways are extensively investigated experimentally and to some extent theoretically (Bagci et al., 2006; Geva-Zatorsky et al., 2006; Levine et al., 2006), one crucial question remains: when faced with different levels of DNA damage, how this network discriminatively regulates arrest, repair and apoptosis, and ultimately makes the best decision?
Another mystery associated with the p53 network is the functional significance of p53 oscillation under certain stress conditions. In 2000, Bar-Or et al. first observed periodic oscillation of nuclear p53 concentration after gamma radiation (Lev Bar-Or et al., 2000). Since then, oscillatory behavior of p53 after DNA damage has been found in several cell types, and in living mice (Hamstra et al., 2006; Ramalingam et al., 2007). A number of theoretical papers have been devoted to understand the mechanism of the oscillation (Ciliberto et al., 2005; Ma et al., 2005; Tiana et al., 2002; Wagner et al., 2005). It is speculated that this oscillation may have certain functional roles in cell fate decision (Tyson, 2006). However, despite these efforts it remains unclear whether and how the p53 oscillation plays any role in coordinating the stress response and/or in the cell-fate decision-making.
In this paper, we aim to address the following questions: (1) whether and how the p53 DNA damage response network uses different information to differentially regulate the pro-survival module and the pro-death module; (2) what is the strategy of the p53 network in the life-death decision making; and (3) what is the possible role of the p53 oscillation in this process. Based on the large amounts of literature on the p53 pathway, we first build a network of p53-mediated response to DNA damage, and then translate the network into ordinary differential equations. Analysis of this system suggests that distinct information of the nuclear p53 concentration is used to regulate the modules of cell cycle arrest and apoptosis: while the cell cycle arrest is determined by the instantaneous or peak values of the nuclear p53, the initiation of apoptosis depends on the time integration of the nuclear p53 level. This strategy gives the cell a time window – the length of which is roughly inversely proportional to the stress level – to recover from the stress before taking the death fate. With such a strategy, nuclear p53 oscillation can be beneficial in intermediate levels of damage – it expands the dynamic range of the differential response of the pro-survival and pro-death modules.
2. Results
2.1. Modeling the p53 DNA damage response network
We focus on the DNA damage caused by radiation. The p53 DNA damage response network that we consider in this work is shown schematically in Figure 1. It consists of three modules: p53 core regulation, p53-induced cell cycle arrest, and p53-dependent apoptosis. For each of these modules, we separately obtain its overall qualitative dynamic behavior by analyzing its bifurcation diagram, which is relatively independent of the model parameters.
Figure 1.
The p53 DNA damage response network. Proteins with similar functions are grouped into one node denoted by their representative members.
The p53 core regulation module is shown in the upper box, which controls the p53 level and its dynamics. Nuclear p53 induces the transcription of Mdm2, while Mdm2 targets p53 for degradation through multistep ubiquitination (Marine et al., 2006). DNA damage induces the phosphorylation of p53 and Mdm2, leading to a lower binding affinity between the two and rapid degradation of Mdm2 (Chehab et al., 2000; Fei & El-Deiry, 2003). As a result, p53 level rises to a “response state” that can trigger downstream events including apoptosis and cell cycle arrest. We assume that the DNA is damaged at time t=0 with a damage level l, and that the damage level is maintained at the constant level l until either the damage is repaired or the cell initiates apoptosis. It is straightforward to generalize to the case of a time-varying damage level, e.g. with the damage level l decreases gradually in time as the damaged DNA being repaired. DNA damage level positively affects two parameters: the phosphorylation rate of p53 and the degradation rate of Mdm2.
While poly-ubiquitinated p53 undergoes degradation, mono-ubiquitinated p53 is exported into the cytoplasm (Salmena & Pandolfi, 2007). We assume that non-nuclear p53 has a longer half-life than nuclear p53. As will be discussed later, this assumption is crucial to our proposed mechanism of life-death decision. Although there are no direct experimental measurements, a longer life-time of non-nuclear p53 is conceivable because: (1) Mdm2 localizes predominantly in the nucleus (Roth et al., 1998), and (2) mono-ubiquitination further targets p53 to the mitochondria where it undergoes de-ubiquitination by HAUSP (Marchenko et al., 2007). This non-ubiquitinated p53 will further evade the ubiquitin-mediated degradation, the major channel for its destruction (Marine et al., 2006). It has been shown that mutated p53 that cannot associate with Mdm2 has a half-life around ten hours (Blagosklonny, 2000; Tang et al., 2006). Thus it is reasonable to assume that the cytoplasmic and mitochondrial p53 (all named mitochondrial p53 thereafter for brevity) has a half-life no less than five hours, the typical period for p53 oscillation (Lev Bar-Or et al., 2000; Ramalingam et al., 2007; Speidel et al., 2006).
At elevated levels, both the nuclear and mitochondrial p53 play key roles in initiating intrinsic apoptosis (Chipuk & Green, 2006) (see bottom-right box of Figure 1). Nuclear p53 down-regulates the transcription of anti-apoptotic proteins such as Bcl2, up-regulates the pro-apoptotic proteins such as Puma and Noxa, and primes Bax and Bak (Cory & Adams, 2002). Meanwhile, when entering the cytoplasm and targeted the mitochondria, p53 directly activates the primed Bax and Bak for their oligomerization (Chipuk, 2004; Leu et al., 2004; Vaseva & Moll, 2008), inducing mitochondrial outer membrane permeabilization (MOMP). MOMP leads to the activation of the death executioner caspase (Cory & Adams, 2002). Caspase will further activate Bax besides its role in mass destruction, forming a positive feedback loop (Cory & Adams, 2002).
In contrast to its role in triggering cell death, p53 also plays important pro-recovery roles after DNA damage. p53 induces the transcription of DNA repair-related genes and may play a direct role in DNA repair and recombination (Gatz & Wiesmuller, 2006). Here we focus on the other pro-survival role of p53: arresting the cell cycle thus preventing the damage from aggravation and spreading, until the damaged DNA is repaired (Fei & El-Deiry, 2003). P53 can arrest cell cycle in G1 or G2 phases. For simplicity, we only consider the G1 arrest (see the bottom-left box of Figure 1). After DNA damage in G1 phase, a rapid destruction of Cdc25A blocks the activation of cycE/Cdk2 (the key complex in G1/S transitoin), inducing a transient cell cycle arrest that can only last for several hours (Bartek & Lukas, 2001); A sustainable cell cycle arrest is realized by nuclear p53 inducing the transcription of p21 (He et al., 2005), a short-lived protein that binds and inhibits both cycD/Cdk4 (the key complex in cell cycle entry (Massagué, 2004)) and cycE/ac-Cdk2 (Maki & Howley, 1997)). .
Some recent studies on the roles of the p53 in cell fate decision emphasized on its post-translational modifications for target-gene selectivity (Olsson et al., 2007; Zhang et al., 2009). Our model does not exclude such a possibility. Yet more than 30 different modification sites with unclear interactions might be too complex for our coarse grained model, and what we are interested is the control of cell fate by the dynamics of p53. The nuclear p53 in our model has both pro-survival and pro-death roles, and it could be viewed as the sum of the p53 with different transcriptional target preferences.
Based on the description above (Figure 1), ordinary differential equation (ODE) models of p53 regulation, apoptosis and G1 arrest modules were constructed. In these models, dimerization (blue line in Figure 1) and transformation (black line) are modeled as elementary reactions; transcription/activation (green line) and inhibition (red line) are modeled using the Hill functions. Model parameters were chosen based on the literature whenever possible, and on the biochemical constraints (Aldridge et al., 2006). The details of the models are presented in the Supplementary Information. The three modules of the p53 network are first analyzed separately by treating the inter-module regulations as control parameters. A full dynamic simulation of the whole system is then followed to confirm the results and conclusions.
2.2. Nuclear p53 concentration oscillates at intermediate levels of DNA damage
Dynamic theory analysis of the p53 regulation module reveals a bifurcation diagram of nuclear p53 concentration as a function of the DNA damage level (Figure 2A). It shows that the dynamic behavior of nuclear p53 undergoes transitions from low steady state to oscillation to high steady state, with increasing DNA damage level. Oscillations appear at the intermediate levels of DNA damage, with a period about 5 hours; a high steady state appears at higher damage level. These results are consistent with existing experimental observations and theoretical modeling (Batchelor et al., 2008; Lev Bar-Or et al., 2000; Ramalingam et al., 2007; Speidel et al., 2006; Wagner et al., 2005). There is evidence that p53 also forms negative feedback loop with its upstream kinases like Wip1, which may influence the shape of its oscillation (Batchelor et al., 2008), for simplicity we do not include them in the main text. In THE supplementary material , analysis of model with both p53-Mdm2 and p53-Wip1-Chk2 loops is carried out, which indicates that this additional negative feedback won’t bring quantitative difference into the bifurcation behavior of p53.
Figure 2.
(A) The phase diagram of the nuclear p53 as a function of the DNA damage level (dark blue). In the central region where nuclear p53 oscillates, the upper and lower branches denote the peak and valley values of the oscillation, respectively. The mean concentration of nuclear p53 is shown in green. (B) The bifurcation diagram of cycE/ac_Cdk2, with the nuclear p53 as the control parameter. Dot indicates stable fixed point, while cycle indicates unstable fixed point.
Note that our analysis does not imply that with increasing DNA damage level the cell will always pass through the entire three phases of low-steady-state, oscillation, and high-steady-state because the damage level required for p53 to be in the high steady state region may be too severe to observe, or the signal might be transuded to the p53 regulation module in a non-linear fashion., Actually, for the model with both Wip1 and Mdm2 feedbacks, about 62% of all parameter sets allow the entire low-oscillation-high bifurcation, and 29% only exhibit the low-steady to oscillation transition (Fig.S2). This partial transition is because that the concentration of Chk2 has been saturated in the intermediate level of damage, and unable to provide p53 a higher signal. . Nonetheless, according to our model, if both the oscillation and a high steady state level of p53 are observed in the same cell, the oscillation generally indicates a less severe damage.
2.3. Mitochondrial p53 is an Integrator of Nuclear p53 Level
As discussed before, it is conceivable that the lifetime of the mitochondria p53 is considerably longer than the typical period of the p53 oscillations. Furthermore, there is no evidence showing that the mitochondria p53 can be actively imported back to the nucleus. If we assume that both the degradation rate and the nuclear reentry rate of the mitochondria p53 are quite small, the amount of the mitochondria p53 would be proportional to the time-integration of the nuclear p53 level. The rate equation for the mitochondria p53 is
(1) |
where [mono_ub_p53] is the concentration of the nuclear mono-ubiquitinated p53 that is being exported to outside of the nucleus at a rate k, and dmito is the sum of the degradation rate and the nuclear reentry rate of the mitochondria p53. In Supplementary Information, we show that [mono_ub_p53] ∝ [nu_p53_total], the total nuclear p53 concentration. Thus, under the assumption of small dmito,
(2) |
Integrating the above equation, we have:
(3) |
We therefore arrived at an important property of the system: the mitochondrial p53 level is approximately proportional to the time integral of the nuclear p53 level. This means that at a low steady-state level of the nuclear p53, the mitochondria p53 accumulates very slowly or does not accumulate at all. At a high steady-state level of the nuclear p53, the mitochondria p53 accumulates rapidly. In the case of an oscillatory nuclear p53, a fraction of the nuclear p53 is exported during each pulse, and the mitochondrial p53 accumulates in a staircase-like manner (Figure 3A).
Figure 3.
(A) A time course of the nuclear p53 (blue), the mitochondrial p53 in total (black) and the time integral of the nuclear p53 (green). The time integral has been normalized to the same scale of the mitochondrial p53. (B) The bifurcation diagrams for the caspase under five different levels of nuclear p53, with the mitochondrial p53 as control parameters.
2.4. Accumulation of mitochondria p53 triggers apoptosis
As shown in Figure 1, both the nuclear p53 and the mitochondria p53 can influence the apoptosis module. Treating the nuclear and the mitochondria p53 concentrations as control parameters and analyzing the ODE of the apoptosis module (Supplementary Information), we obtain the bifurcation diagram of the apoptosis executioner caspase (Figure 3B). The switching-on of the caspase activity from low to high (via a saddle-node bifurcation) only happens when both the nuclear and the mitochondria p53 are above certain thresholds. However, the switch to the apoptotic state is mainly triggered by the accumulation of the mitochondrial p53.As shown in the figure, once nuclear p53 exceeds certain threshold (between 0.2 −0.4 uM), the switch from low caspase to high caspase level is mainly driven by the increase of mitochondrial p53 concentration. Also, the relatively slow time scale for the mitochondrial p53 accumulation makes it the time-limiting step for apoptosis initiation.
Although the majority of p53 localizes inside the nucleus, biological evidence supports the critical role of the mitochondrial p53 in apoptosis initiation. Speidel et al. observed that NIH3T3 cells go to cell cycle arrest and apoptosis under low and high doses of radiation, respectively (Speidel et al., 2006). Comparing the cells with the two different fates, the expression of the pro-apoptotic proteins transcribed by the nuclear p53 does not have any obvious difference, while the mitochondrial p53 levels differ markedly (Speidel et al., 2006). Furthermore, inhibition of the mitochondrial p53 leads to the protection of mice from apoptosis, while the transcriptional function of p53 is not impaired (Strom et al., 2006).
As the accumulation of the mitochondria p53 is mainly responsible to trigger apoptosis and the mitochondrial p53 is an integrator of the nuclear p53 (Eq. (3)), we reach the conclusion that the nuclear p53 controls apoptosis through its time integration.
2.5. Peak Values of Nuclear p53 Arrest Cell Cycle
The bistability nature of the cell-cycle arrest module has previously been suggested and observed (Yao et al., 2008). The p53-controlled bifurcations diagram of the cell cycle arrest module obtained from our model analysis is shown in Figure 2B . With increased concentration of nuclear p53, the level of cycE/ac-Cdk2 undergoes a sudden transition from the high-value branch (cell cycle progression) to the low-value branch (cell cycle arrest) via a saddle node bifurcation (Point A in Figure 2B). The activation rate of cycE/Cdk2, which is influenced by the Cdc25A mediated rapid arrest pathway, shifts the positions of transition point but maintains the shape of bifurcation diagram (Fig. S6)
Due the bistability nature of the phase diagram, once the cell cycle is arrested, the nuclear p53 level has to decrease to a much lower value (Point B in Figure 2B) for the cell cycle to resume. Thus, in the case of an oscillatory nuclear p53 level, it suffices to have the peak values exceeding the threshold (Point A in Figure 2B) to arrest the cell cycle. Furthermore, the p53-assisted cell cycle arrest happens usually within an hour once the p53 rises to a high level (Bartek & Lukas, 2001; He et al., 2005). This arrest mechanism is named as “slow arrest” because it takes several hours for boost p53 up after damage; once nuclear p53 increases to the threshold height, G1 progression is blocked almost immediately (Toettcher et al., 2009). On the contrast, the G1 progression has a longer time scale of the order of 10 hours (Cooper, 1997). Thus, in the case of nuclear p53 oscillating between a high and a low level, even if the low level is below the point B in Figure 2B, the cell cycle progression may not have time to resume before the next high value of p53 comes again. Results from our simulation of the full dynamic model confirmed this. Therefore, the peak values of the nuclear p53 determine the cell cycle arrest and its maintenance.
3. Discussion
3.1. The information processing strategy of the DNA damage response network
Our analyses of the p53 network suggest that the cell uses different aspects of the information from the nuclear p53 profile to differentially regulate pro-survival and pro-death modules. Cell cycle arrest depends on the present status of the nuclear p53 level – once the nuclear p53 level is above certain threshold the cell cycle is arrested. On the other hand, the initiation of apoptosis depends on the accumulation of the mitochondria p53, which is roughly proportional to the time-integration of the nuclear p53 level (Eq. 3). The integration-dependent apoptosis initiation can be beneficial, as in this case the cell fate is determined not only by the degree of the DNA damage but also by the perceived ability for the cell to repair it. Corresponding to each damage level, the cell sets up a timer for apoptosis initiation. If the cell repairs the damaged DNA within the time window, the concentration of p53 drops and the timer is stopped – the cell chooses the fate of survival. Otherwise, the timer sets off and the cell dies.
Since the average nuclear p53 level correlates positively with the damage level (see Figure 2A), the time for the mitochondria p53 to reach a threshold (to trigger apoptosis) is roughly inversely proportional to the damage level. That is, the higher the damage level is, the faster the cell will commit to apoptosis and thus leaving a smaller time window for the cell to repair its damaged DNA. In Figure 4, we show the dynamic behavior of key proteins for three different levels of DNA damage. At a very small damage level (Figure 4A), the nuclear p53 level is very low and the mitochondria p53 never accumulates to a substantial level. The cell continues to divide and no apoptosis will be initiated, no matter how long the damage lasts. At an intermediate damage level (Figure 4B), the nuclear p53 oscillates, the cell cycle is arrested, and the mitochondria p53 accumulates with time. If the cell does not repair its damaged DNA (thus reducing the p53 level) in about 35 hours, the caspase is activated and the cell enters the irreversible process of apoptosis. At a high level of damage (Figure 4C), the nuclear p53 is maintained at a high level and the mitochondria p53 accumulates fast. In this case, if the cell does not repair its damaged DNA in about 10 hours, the apoptosis will take place.
Figure 4.
Dynamics behavior of key proteins in low(A), intermediate (B) and high (C) damage levels. (blue: nuclear p53, indicates the dynamics of p53 module; red: caspase, indicates the initiation of apoptosis; and green: cycE/CDK2, indicates the progression/arrest of G1 cell cycle)
This behavior of a decreasing survival rate with increasing damage level is summarized in Figure 5, in which the dependence of cell fates on damage level and damage duration is shown. The red line separating life from death indicates the time window at a given damage level, beyond which the cell will die if the damaged DNA is not repaired. The inverse dependence of time window on the damage level is a smart strategy. The more severe the damage is, the smaller the chance to completely repair it, and potentially the more dangerous it is to the organism. Thus, to maximize the probability of the survival of the whole organism, it is reasonable to give the less damaged cells more chance (time) to recover and to be more “intolerable” to the more damaged cells.
Figure 5.
The phase diagram of the cell fate as functions of the damage level and the damage duration. The green line is the onset of cell cycle arrest. The red line is the onset of apoptosis. The integers on the steps of the red line indicate the number of oscillation periods after which the cell will start apoptosis.
3.2.The possible function of the nuclear p53 oscillation
An oscillatory or pulsatile nuclear p53 have the characteristic property of a high peak value, but a much lower value of the time integration compared with a constant profile of the same peak value. If the pro-survival modules are activated/maintained by the instantanious value and the apoptosis is triggered by the time integration, oscillating nuclear p53 would effectively activate the pro-survival modules with its high peak value and at the same time not accelerating the pace of apoptosis. Indeed, as shown in Figure 2A, p53 oscillation appears in the intermediate levels of damage – under potentially reparable damage, the cell prefers survival with high p53 peak value yet low integral value.
In all previous analysis, DNA damage signal is treated as a constant (Fig.2, Fig.4) or a rectangular function (Fig.5). we also tested a time-decaying damage signal with the decay rate controlled by both p53-dependent transcription and the intrinsic repair ability of the cell (See supplementary material). As the pro-survival program still depends on the instantaneous level of nuclear p53, the cell fate determination diagram (Fig. S6B) shows similar pattern as that in Fig. 5. In general, an oscillating nuclear p53 brings itself a larger dynamic range while keeping the accumulation of the mitochondria p53 at a controlled pace.
Note that under severe damages, the nuclear p53 takes high steady-state values (Figure 2A). In this case, the cell goes faster into the apoptotic phase than with an oscillatory p53, even when the high steady-state concentration of the p53 is lower than the peak value of oscillation (compare Figure 4C with 4B). Cell death is therefore preferred under high damage levels.
3.3.General strategy for cell decision-making in stress response
Some other stress response pathways seem to share the similar structure with that of the p53 network. For example, the Nf-κB pathways involve both pro-survival and pro-death responses and the oscillatory behavior of some key regulators was observed (Ashall et al., 2009; Hoffmann et al., 2002; Krishna et al., 2006). In the endoplasmic reticulum unfolded protein response pathways, the same regulators were shown to activate both the protective and the apoptotic responses (Han et al., 2009; Lin et al., 2007), and the cell fate depends on the strength and the duration of the stress (Degterev et al., 2003). Our proposed cell-fate decision-making strategy for the p53 network may also apply to these systems and may be rather general in stress response systems of eukaryotes. The theory can be verified or falsified with quantitative experiments, for example, by simultaneously monitoring the p53 concentrations in the nucleus and the cytoplasm, their dynamic behaviors, and the probability of apoptosis with varying degrees of irradiation.
Materials and Methods
The bifurcation diagrams were obtained using Matlab. The dynamic simulations of the differential equations were carried out with Maltlab and C++.
Supplementary Material
Author Summary.
When a mammalian cell is damaged or stressed, it has two choices: to recover from the stress or to kill itself. “To be or not to be” – which cell fate to take under the circumstance – is an important decision for the cell to make for the whole organism’s well being. Some complex diseases are known to be associated with tipping the balance between life and death of the stressed cells. While it is known that the cell may activate both the pro-recovery and the pro-death pathways simultaneously, often by the same response-regulator, it is unclear how the life-death decision is being made. We have constructed a mathematical model for the cell’s DNA damage response pathways. Our computational analyses suggested that the regulator (in this case, the tumor suppressor protein p53) uses different aspects of its activation profile to differentially regulate life and death. While the recovery pathway is dependent on the current or recent p53 activity, the death will come as a result of the history or time integration of the p53 profile. This strategy gives a less stressed cell more time to recover than a more stressed cell. Our work also provides a functional explanation for the observed oscillation in the nuclear p53 concentration.
Acknowledgements
We would like to thank members of the network group in Center for Theoretical Biology at Peking University for discussions.
References
- Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK. Physicochemical modelling of cell signalling pathways. Nat Cell Biol. 2006;8(11):1195–1203. doi: 10.1038/ncb1497. [DOI] [PubMed] [Google Scholar]
- Ashall L, Horton CA, Nelson DE, Paszek P, Harper CV, Sillitoe K, Ryan S, Spiller DG, Unitt JF, Broomhead DS, Kell DB, Rand DA, See V, White MR. Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription. Science. 2009;324(5924):242–246. doi: 10.1126/science.1164860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bagci EZ, Vodovotz Y, Billiar TR, Ermentrout GB, Bahar I. Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. Biophys J. 2006;90(5):1546–1559. doi: 10.1529/biophysj.105.068122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bartek J, Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 2001;490(3):117–122. doi: 10.1016/s0014-5793(01)02114-7. [DOI] [PubMed] [Google Scholar]
- Batchelor E, Mock CS, Bhan I, Loewer A, Lahav G. Recurrent Initiation: A Mechanism for Triggering p53 Pulses in Response to DNA Damage. Molecular Cell. 2008;30(3):277–289. doi: 10.1016/j.molcel.2008.03.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blagosklonny MV. p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect. Faseb J. 2000;14(13):1901–1907. doi: 10.1096/fj.99-1078rev. [DOI] [PubMed] [Google Scholar]
- Braithwaite AW, Prives CL. p53: more research and more questions. Cell Death Differ. 2006;13(6):877–880. doi: 10.1038/sj.cdd.4401938. [DOI] [PubMed] [Google Scholar]
- Chehab NH, Malikzay A, Appel M, Halazonetis TD. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 2000;14(3):278–288. [PMC free article] [PubMed] [Google Scholar]
- Chipuk JE. Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis. Science. 2004;303(5660):1010–1014. doi: 10.1126/science.1092734. [DOI] [PubMed] [Google Scholar]
- Chipuk JE, Green DR. Dissecting p53-dependent apoptosis. Cell Death Differ. 2006;13(6):994–1002. doi: 10.1038/sj.cdd.4401908. [DOI] [PubMed] [Google Scholar]
- Ciliberto A, Novak B, Tyson JJ. Steady states and oscillations in the p53/Mdm2 network. Cell Cycle. 2005;4(3):488–493. doi: 10.4161/cc.4.3.1548. [DOI] [PubMed] [Google Scholar]
- Cooper GM. The cell : a molecular approach. ASM Press; 1997. [Google Scholar]
- Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nature Reviews Cancer. 2002;2(9):647–656. doi: 10.1038/nrc883. [DOI] [PubMed] [Google Scholar]
- Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene. 2003;22(53):8543–8567. doi: 10.1038/sj.onc.1207107. [DOI] [PubMed] [Google Scholar]
- Fei P, El-Deiry WS. P53 and radiation responses. Oncogene. 2003;22(37):5774–5783. doi: 10.1038/sj.onc.1206677. [DOI] [PubMed] [Google Scholar]
- Ferrell JE., Jr Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr Opin Cell Biol. 2002;14(2):140–148. doi: 10.1016/s0955-0674(02)00314-9. [DOI] [PubMed] [Google Scholar]
- Gatz SA, Wiesmuller L. p53 in recombination and repair. Cell Death Differ. 2006;13(6):1003–1016. doi: 10.1038/sj.cdd.4401903. [DOI] [PubMed] [Google Scholar]
- Geva-Zatorsky N, Rosenfeld N, Itzkovitz S, Milo R, Sigal A, Dekel E, Yarnitzky T, Liron Y, Polak P, Lahav G, Alon U. Oscillations and variability in the p53 system. Molecular Systems Biology. 2006;2 doi: 10.1038/msb4100068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hamstra DA, Bhojani MS, Griffin LB, Laxman B, Ross BD, Rehemtulla A. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer research. 2006;66(15):7482–7482. doi: 10.1158/0008-5472.CAN-06-1405. [DOI] [PubMed] [Google Scholar]
- Han D, Lerner AG, Vande Walle L, Upton JP, Xu W, Hagen A, Backes BJ, Oakes SA, Papa FR. IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell. 2009;138(3):562–575. doi: 10.1016/j.cell.2009.07.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- He G, Siddik ZH, Huang Z, Wang R, Koomen J, Kobayashi R, Khokhar AR, Kuang J. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene. 2005;24(18):2929–2943. doi: 10.1038/sj.onc.1208474. [DOI] [PubMed] [Google Scholar]
- Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science. 2002;298(5596):1241–1245. doi: 10.1126/science.1071914. [DOI] [PubMed] [Google Scholar]
- Krishna S, Jensen MH, Sneppen K. Minimal model of spiky oscillations in NF-kappaB signaling. Proc Natl Acad Sci U S A. 2006;103(29):10840–10845. doi: 10.1073/pnas.0604085103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A. 1992;89(16):7491–7495. doi: 10.1073/pnas.89.16.7491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol. 2004;6(5):443–450. doi: 10.1038/ncb1123. [DOI] [PubMed] [Google Scholar]
- Lev Bar-Or R, Maya R, Segel LA, Alon U, Levine AJ, Oren M. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc Natl Acad Sci U S A. 2000;97(21):11250–11255. doi: 10.1073/pnas.210171597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Levine AJ, Hu W, Feng Z. The P53 pathway: what questions remain to be explored? Cell Death Differ. 2006;13(6):1027–1036. doi: 10.1038/sj.cdd.4401910. [DOI] [PubMed] [Google Scholar]
- Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, Shokat KM, Lavail MM, Walter P. IRE1 signaling affects cell fate during the unfolded protein response. Science. 2007;318(5852):944–949. doi: 10.1126/science.1146361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ma L, Wagner J, Rice JJ, Hu W, Levine AJ, Stolovitzky GA. A plausible model for the digital response of p53 to DNA damage. Proc Natl Acad Sci U S A. 2005;102(40):14266–14271. doi: 10.1073/pnas.0501352102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maki CG, Howley PM. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol Cell Biol. 1997;17(1):355–363. doi: 10.1128/mcb.17.1.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marchenko ND, Wolff S, Erster S, Becker K, Moll UM. Monoubiquitylation promotes mitochondrial p53 translocation. The EMBO journal. 2007;26(4):923–934. doi: 10.1038/sj.emboj.7601560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marine JC, Francoz S, Maetens M, Wahl G, Toledo F, Lozano G. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death & Differentiation. 2006;13(6):927–934. doi: 10.1038/sj.cdd.4401912. [DOI] [PubMed] [Google Scholar]
- Massagué J. G1 cell-cycle control and cancer. Nature. 2004;432(7015):298–306. doi: 10.1038/nature03094. [DOI] [PubMed] [Google Scholar]
- Olsson A, Manzl C, Strasser A, Villunger A. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ. 2007;14(9):1561–1575. doi: 10.1038/sj.cdd.4402196. [DOI] [PubMed] [Google Scholar]
- Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature. 1997;389(6648):300–304. doi: 10.1038/38525. [DOI] [PubMed] [Google Scholar]
- Ramalingam S, Honkanen P, Young L, Shimura T, Austin J, Steeg PS, Nishizuka S. Quantitative assessment of the p53-Mdm2 feedback loop using protein lysate microarrays. Cancer research. 2007;67(13):6247–6247. doi: 10.1158/0008-5472.CAN-07-0342. [DOI] [PubMed] [Google Scholar]
- Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. The EMBO journal. 1998;17(2):554–564. doi: 10.1093/emboj/17.2.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Salmena L, Pandolfi PP. Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation. Nature Reviews Cancer. 2007;7(6):409–413. doi: 10.1038/nrc2145. [DOI] [PubMed] [Google Scholar]
- Speidel D, Helmbold H, Deppert W. Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene. 2006;25(6):940–953. doi: 10.1038/sj.onc.1209126. [DOI] [PubMed] [Google Scholar]
- Strom E, Sathe S, Komarov PG, Chernova OB, Pavlovska I, Shyshynova I, Bosykh DA, Burdelya LG, Macklis RM, Skaliter R, Komarova EA, Gudkov AV. Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol. 2006;2(9):474–479. doi: 10.1038/nchembio809. [DOI] [PubMed] [Google Scholar]
- Tang M, Wahl GM, Nister M. Explaining the biological activity of transactivation-deficient p53 variants. Nat Genet. 2006;38(4):395–396. doi: 10.1038/ng0406-395. author reply 396–7. [DOI] [PubMed] [Google Scholar]
- Tiana G, Jensen MH, Sneppen K. Time delay as a key to apoptosis induction in the p53 network. The European Physical Journal B-Condensed Matter and Complex Systems. 2002;29(1):135–140. [Google Scholar]
- Toettcher JE, Loewer A, Ostheimer GJ, Yaffe MB, Tidor B, Lahav G. Distinct mechanisms act in concert to mediate cell cycle arrest. Proceedings of the National Academy of Sciences. 2009;106(3):785–790. doi: 10.1073/pnas.0806196106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tyson JJ. Another turn for p53. Mol Syst Biol. 2006;2 doi: 10.1038/msb4100060. 2006 0032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vaseva AV, Moll UM. The mitochondrial p53 pathway. Biochim Biophys Acta. 2008 doi: 10.1016/j.bbabio.2008.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wagner J, Ma L, Rice JJ, Hu W, Levine AJ, Stolovitzky GA. p53-Mdm2 loop controlled by a balance of its feedback strength and effective dampening using ATM and delayed feedback. Syst Biol (Stevenage) 2005;152(3):109–118. doi: 10.1049/ip-syb:20050025. [DOI] [PubMed] [Google Scholar]
- Yao G, Lee TJ, Mori S, Nevins JR, You L. A bistable Rb-E2F switch underlies the restriction point. Nat Cell Biol. 2008;10(4):476–482. doi: 10.1038/ncb1711. [DOI] [PubMed] [Google Scholar]
- Zhang XP, Liu F, Cheng Z, Wang W. Cell fate decision mediated by p53 pulses. Proc Natl Acad Sci U S A. 2009 doi: 10.1073/pnas.0813088106. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.